What infusion rate should I program for a 55‑kg patient using a 16 mg norepinephrine (in 250 mL) solution to deliver 0.05 µg·kg⁻¹·min⁻¹?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Norepinephrine Infusion Rate Calculation

For a 55-kg patient using a 16 mg norepinephrine in 250 mL solution to deliver 0.05 µg·kg⁻¹·min⁻¹, program the infusion pump to 2.6 mL/h.

Calculation Method

The concentration of your prepared solution is:

  • 16 mg norepinephrine in 250 mL = 64 µg/mL

For a 55-kg patient requiring 0.05 µg·kg⁻¹·min⁻¹:

  • Dose needed = 0.05 µg/kg/min × 55 kg = 2.75 µg/min

To convert to mL/h:

  • (2.75 µg/min ÷ 64 µg/mL) × 60 min/h = 2.58 mL/h
  • Round to 2.6 mL/h for practical pump programming

Clinical Context

This 16 mg/250 mL concentration (64 µg/mL) is a validated standard concentration supported by multi-institutional analysis 1. The FDA label confirms norepinephrine should be titrated to hemodynamic response, with typical starting doses of 8-12 µg/min (0.1-0.15 µg/kg/min for a 70-kg adult) 2.

Your prescribed dose of 0.05 µg/kg/min falls within the lower end of the recommended starting range of 0.1-0.5 µg/kg/min per AHA guidelines 3 and is appropriate for initial hemodynamic support. The Surviving Sepsis Campaign recommends norepinephrine as first-line vasopressor therapy, titrated to achieve a mean arterial pressure ≥65 mmHg 4, 5.

Safety Considerations

  • Administer through a central line whenever possible to minimize extravasation risk 3, 2
  • Dilute only in 5% dextrose solutions (not saline alone) to prevent oxidation and loss of potency 2
  • Monitor blood pressure every 1-2 minutes initially, then continuously once stable
  • If extravasation occurs, infiltrate the site with 5-10 mg phentolamine diluted in 10-15 mL saline immediately 3, 6
  • Titrate to clinical effect, not to a fixed dose—hemodynamic response varies significantly between patients 2

Dose Titration Algorithm

  1. Start at 2.6 mL/h (0.05 µg/kg/min)
  2. Assess response every 2-5 minutes: Check MAP, perfusion markers (skin temperature, capillary refill, urine output, mental status)
  3. If MAP remains <65 mmHg or inadequate perfusion: Increase by 1-2 mL/h increments (approximately 0.025-0.05 µg/kg/min)
  4. Typical maintenance range: 5-15 mL/h with this concentration (0.1-0.3 µg/kg/min)
  5. If requiring >20 mL/h (>0.5 µg/kg/min): Consider adding vasopressin 0.03 units/min rather than escalating norepinephrine further 4, 5

Common pitfall: Ensure adequate fluid resuscitation before initiating vasopressors—norepinephrine is relatively contraindicated in hypovolemia 3. If high doses are needed, suspect occult volume depletion and reassess fluid status 2.

References

1
Research

Using intravenous pump infusion data to optimize continuous infusion concentrations and reduce drug and fluid waste.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2020

Related Questions

How should norepinephrine (noradrenaline) be prescribed as an intravenous continuous infusion for an adult patient with hypotension or shock?
In a 65-year-old woman with diabetes mellitus and a remote myocardial infarction who is in septic shock from urosepsis, receiving norepinephrine, remains hypoxic despite 100% FiO₂, has bilateral lung infiltrates on chest X‑ray, and pulmonary artery catheter data showing low right atrial pressure, low pulmonary artery pressure, low pulmonary capillary wedge pressure, and normal cardiac output, what is the most likely cause of the bilateral lung infiltrates?
In a patient with septic shock whose blood pressure remains low despite adequate fluid resuscitation and norepinephrine (or other vasopressor) support, what adjunctive therapies should be administered?
How should a double‑strength norepinephrine infusion be initially started?
How should I target a net negative fluid balance of 1–2 L per day in a septic shock patient who is hemodynamically stable (MAP ≥ 65 mmHg, stable or decreasing vasopressors, falling lactate, urine output ≥ 0.5 mL/kg/h)?
Is it safe to initiate Eye Movement Desensitization and Reprocessing (EMDR) therapy in a patient currently taking benzodiazepines, and what is the recommended approach for managing benzodiazepine use?
In a patient on chronic hemodialysis, can the hepatitis B vaccine and seasonal influenza vaccine be administered at the same visit?
What norepinephrine infusion rate should be started for a 55‑kg patient (in µg·kg⁻¹·min⁻¹ and the corresponding mL·h⁻¹)?
Can ursodeoxycholic acid (UDCA) cause loose stools in infants?
What could be causing knee pain on the leg used for the accelerator while driving?
What does it mean when a radiologist describes calcification as hemodynamically significant?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.